Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 113.83 billion. The enterprise value is 131.09 billion.
Market Cap | 113.83B |
Enterprise Value | 131.09B |
Important Dates
The last earnings date was Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sanofi has 1.25 billion shares outstanding. The number of shares has decreased by -0.05% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.25B |
Shares Change (YoY) | -0.05% |
Shares Change (QoQ) | -0.46% |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 57.60% |
Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 25.30 and the forward PE ratio is 10.83. Sanofi's PEG ratio is 1.24.
PE Ratio | 25.30 |
Forward PE | 10.83 |
PS Ratio | 2.35 |
PB Ratio | 1.56 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 1.24 |
Enterprise Valuation
EV / Earnings | 29.09 |
EV / Sales | 2.71 |
EV / EBITDA | 10.30 |
EV / EBIT | 14.73 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.33 |
Debt / EBITDA | 1.86 |
Debt / FCF | n/a |
Interest Coverage | 12.99 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 5.88% |
Revenue Per Employee | 562,738 |
Profits Per Employee | 52,342 |
Employee Count | 86,088 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.04% in the last 52 weeks. The beta is 0.42, so Sanofi's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | +6.04% |
50-Day Moving Average | 99.18 |
200-Day Moving Average | 93.70 |
Relative Strength Index (RSI) | 25.61 |
Average Volume (20 Days) | 1,543,827 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 48.45 billion and earned 4.51 billion in profits. Earnings per share was 3.59.
Revenue | 48.45B |
Gross Profit | 33.48B |
Operating Income | 8.96B |
Pretax Income | 6.06B |
Net Income | 4.51B |
EBITDA | 12.50B |
EBIT | 8.96B |
Earnings Per Share (EPS) | 3.59 |
Balance Sheet
The company has 6.80 billion in cash and 23.75 billion in debt, giving a net cash position of -16.96 billion or -13.53 per share.
Cash & Cash Equivalents | 6.80B |
Total Debt | 23.75B |
Net Cash | -16.96B |
Net Cash Per Share | -13.53 |
Equity (Book Value) | 73.00B |
Book Value Per Share | 58.10 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 69.12%, with operating and profit margins of 18.50% and 9.30%.
Gross Margin | 69.12% |
Operating Margin | 18.50% |
Pretax Margin | 12.50% |
Profit Margin | 9.30% |
EBITDA Margin | 25.81% |
EBIT Margin | 18.50% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.76, which amounts to a dividend yield of 4.14%.
Dividend Per Share | 3.76 |
Dividend Yield | 4.14% |
Dividend Growth (YoY) | 5.62% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.05% |
Shareholder Yield | 4.19% |
Earnings Yield | 3.95% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |